NBMTM BCMTMS Prüfungsthemen:
| Abschnitt | Gewichtung | Ziele |
|---|---|---|
| Thema 1: Interessenvertretung für die Patientenversorgung | 13% | |
| Thema 2: Pharmakotherapie | 62% | |
| Thema 3: Dokumentation und Abrechnung | 7% | |
| Thema 4: Grundlagen des Medication Therapy Management | 13% | - Definition und Umsetzung in die Praxis |
| Thema 5: Grundlagen der Pharmakogenomik | 5% |
NBMTM Board Certified Medication Therapy Management Specialist BCMTMS Prüfungsfragen mit Lösungen
1. A 71-year-ow patient who was recently diagnosed withheart failurepresents for a comprehensive medication review. The pharmacist notes that a I of the patient's medications are up to date except eplerenone,which shows as 98 days past due for a refill When the pharmacist inquires about this, the patient responds by saying.
"My insurance does not cover this medication and i cannot afford the cash price " The pharmacist tens the patient spironolactone would be a cheaper option andhas shown to be just as effectivefor heart failure as eplerenone.The patient responds by saying. "Well, can you tell that to my doctor?" Which style of communication shouldthe pharmacist use while calling the patient's prescriber?
A) Aggressive
B) Assertive
C) Passive
D) Passive-aggressive
2. Which activity is performed by a pharmacist during the medication therapy review process?
A) Collaborate with a patient's physician.
B) Create action steps for a patient to follow.
C) Interpret, monitor, and assess a patient's laboratory results.
D) Make a formal, comprehensive medication record for a patient.
3. The OutcomesMTM compensation model for medication therapy management (MTM) is BEST described as which type of model?
A) Fee-for-service
B) Capitation
C) Value-based
D) Hybrid of fee-for-service and value-based
4. Which immunosuppressant requires screening for symptoms of post-transplant lymphoproliferative disorders and progressive mulitifocal leukoencephalopathy with counseling and education as pan of a Risk evaluation and Mitigation Strategy?
A) Belatacept
B) Cyclosporine
C) Azathioprine
D) Tacrolimus
5. A prescription is faxed over for a new patient for methotrexate 7.5mg. Upon reviewing the prescription claim, the pharmacist realizes there is a DUR rejection and realizes it is regarding the days' supply. When the prescription was sent over, it was written for 4 tablets by mouth daily instead of weekly, making the days' supply 4 days instead of 30 days. Knowing that methotrexate is a high-risk medication and can either be taken weekly for rheumatoid arthritis or daily for cancer, which of the following actions should the pharmacist perform NEXT to resolve the DUR rejection?
A) Ask the patient how they are supposed to take the medication
B) Override the rejection claim and counsel patient to take daily.
C) Call the prescriber and verify the directions of the prescription and diagnosis code.
D) Have the pharmacy technician verify the DUR with the patient.
Fragen und Antworten:
| 1. Frage Antwort: B | 2. Frage Antwort: A | 3. Frage Antwort: B | 4. Frage Antwort: B | 5. Frage Antwort: C |
1110 Kundenbewertungen
